The Pharmabiotics Conference is not just another scientific meeting. Now firmly established as the Conference of D&R (Development & Regulation): where Discovery is translated into Development, guided by Direction from Regulation, built on Dialogue across disciplines and with authorities, and driven by the Disruption that microbiome science brings to health, food systems, and sustainability.

What sets this conference apart is its focus on regulatory case studies. With regulatory frameworks still under construction, researchers and developers share their journeys, real-world experiences that become practical case studies for the entire community. These insights are not only about presenting science, but about turning individual challenges into collective knowledge.

This unique positioning is clearly reflected in the conference programme, where every session is grounded in rigorous science and shaped by the voices of industry, academia, and regulators. It is this combination of scientific depth and real-world perspective that makes Pharmabiotics a reference point for microbiome development and regulation in Europe and beyond.

Pharmabiotics 2027 is currently in preparation. Final dates will be announced soon.

Backed by the Pharmabiotic Research Institute (PRI), an independent EU non-profit and recognized stakeholder, the conference ensures that the dialogue between science and regulation carries real weight with regulators, industry, and academia alike.